A Multicenter Study on the Prognostic Value of Indicators Derived From Complete Blood Count in Glioblastoma
Shiqiang Hou, Qihong Gu, Tao Yang, Yiwen Hou, Min Wang, Yu Pan, Chunjing Jin, Ning Lin · 2025
Read A Multicenter Study on the Prognostic Value of Indicators Derived From Complete Blood Count in Glioblastoma by Shiqiang Hou, Qihong Gu, Tao Yang, Yiwen Hou, Min Wang, Yu Pan, Chunjing Jin, Ning Lin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12767395.txt.
Description
Shiqiang Hou leads an eight-author team testing whether routine blood counts predict glioblastoma outcomes, in a study published in two thousand twenty-five. Glioblastoma is the most aggressive common brain tumor. Cheap prognostic markers would help clinicians counsel patients and plan follow-up.
The multicenter study gathered 143 patients' records. Twelve indexes from preoperative blood counts were evaluated. Ratios like neutrophil-to-lymphocyte and platelet-to-lymphocyte capture inflammation's balance. Distribution widths and composite inflammation scores joined them. Earlier single-center results had conflicted, motivating the broader sample. The authors comprehensively assessed which indexes carry genuine prognostic value. Blood-based markers will never replace imaging or genetics, but they cost almost nothing to obtain.
Catalog record
| CREATOR | Shiqiang Hou, Qihong Gu, Tao Yang, Yiwen Hou, Min Wang, Yu Pan, Chunjing Jin, Ning Lin |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |